OPEXA THERAPEUTICS, INC.
2635 Technology Forest Blvd.
The Woodlands, TX 77381
August 8, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Opexa Therapeutics, Inc. - Registration Statement – Form S-4 (File No. 333-219358) |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Opexa Therapeutics, Inc. (the “Registrant”) hereby requests that the effective date of the above-captioned registration statement onForm S-4 (as amended, the “Registration Statement”), be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on August 10, 2017 or as soon thereafter as may be practicable. Please call Patty DeGaetano of Pillsbury Winthrop Shaw Pittman LLP at (858) 509-4033 to confirm the effectiveness of the Registration Statement.
Sincerely, | ||
OPEXA THERAPEUTICS, INC. | ||
By: | /s/ Neil K. Warma | |
Neil K. Warma President, Chief Executive Officer and Acting Chief Financial Officer |
cc: | Mike Hird, Esq. Patty DeGaetano, Esq. |